Abbott Laboratories

Open: 105.19 Close: 104.05 Change: -1.14

Our AI found 5 flaws in Abbott Laboratories Stock.

The game is changing. There is a new strategy to evaluate Abbott Laboratories fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Abbott Laboratories are: Abbott, Laboratories, market, ABT, growth, close, short, …

Concept Map

Semantic Network

Stock Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products. The company operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Diagnostic segment offers laboratory systems in the.

Today's Summary

Abbott Laboratories closed $11.78 short of its 52-week high ($115.83) Shares of Abbott Laboratories ABT slid 0.85% to $104.05 Thursday, on what proved to be an all-around positive trading.

Today's News

Abbott Laboratories closed $11.78 short of its 52-week high ($115.83) Shares of Abbott Laboratories ABT slid 0.85% to $104.05 Thursday, on what proved to be an all-around positive trading session for the stock market. Abbott Laboratories: A must-have in a defensive dividend growth portfolio (nyse:abt) Share Price as of December 7 4:00:00 PM EST. Future ROE for Abbott Laboratories is predicted to rise to 20% despite there being not much change expected in its payout ratio. Biomarkers market size to grow by USD 56.26 billion from 2022 to 2027, progressing at a CAGR of 13.05% as per the latest Technavio market research report. The biomarkers market is fragmented and vendors are deploying organic and inorganic growth strategies to compete. Abbott Laboratories (ABT) is down -0.85% in the last 24 hours. The current market price of 104.05 USD is Overvalued by 12%.

Stock Profile

"Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois."

Keywords

How much time have you spent trying to decide whether investing in Abbott Laboratories? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Abbott Laboratories are: Abbott, Laboratories, market, ABT, growth, close, short, and the most common words in the summary are: abbott, stock, laboratory, market, price, top, news, . One of the sentences in the summary was: Abbott Laboratories closed $11.78 short of its 52-week high ($115.83) Shares of Abbott Laboratories ABT slid 0.85% to $104.05 Thursday, on what proved to be an all-around positive trading.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbott #stock #laboratory #market #price #top #news.